Tech Company Financing Transactions

Mainstay Medical Funding Round

Gilde Healthcare Partners, Viking Global Investors and Ally Bridge Group participated in a $125 million funding round for Mainstay Medical. The funding round was recorded on 2/27/2024.

Transaction Overview

Company Name
Mainstay Medical
Announced On
2/27/2024
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Undisclosed
Investors

Gilde Healthcare Partners (Lead Investor)

Viking Global Investors (Lead Investor)

Ally Bridge Group

Fountain Healthcare Partners

Perceptive Advisors

Sofinnova Partners

Proceeds Purpose
The company intends to use the funds to support its continued commercial growth of ReActiv8® Restorative Neurostimulation in the U.S., Europe and Australia, additional post-market clinical studies and research, and general operations.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2159 India St 200
San Diego, CA 92101
USA
Phone
(877) 702-8488
Website
www.mainstaymedical.com
Email Address
[email protected]
Overview
We are a global medical device company offering therapeutic solutions and new hope for adults suffering from chronic pain. We aim to transform patients' lives everyday by alleviating pain and improving function. Mainstay Medical is led by a team of dedicated scientists, executives, engineers, and clinical experts who leverage their collective experience to develop and commercialize technologies that address unmet clinical needs.
Profile
Mainstay Medical LinkedIn Company Profile
Social Media
Mainstay Medical Company Twitter Account
Company News
Mainstay Medical News
Facebook
Mainstay Medical on Facebook
YouTube
Mainstay Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jason Hannon
  Jason Hannon LinkedIn Profile  Jason Hannon Twitter Account  Jason Hannon News  Jason Hannon on Facebook
Chief Financial Officer
Matt Onaitis
  Matt Onaitis LinkedIn Profile  Matt Onaitis Twitter Account  Matt Onaitis News  Matt Onaitis on Facebook
General Manager
Boris Deutschmann
  Boris Deutschmann LinkedIn Profile  Boris Deutschmann Twitter Account  Boris Deutschmann News  Boris Deutschmann on Facebook
Vice President
Jim Youssef
  Jim Youssef LinkedIn Profile  Jim Youssef Twitter Account  Jim Youssef News  Jim Youssef on Facebook
VP - Bus. Development
Pat Leon
  Pat Leon LinkedIn Profile  Pat Leon Twitter Account  Pat Leon News  Pat Leon on Facebook
VP - Engineering
Chris Linden
  Chris Linden LinkedIn Profile  Chris Linden Twitter Account  Chris Linden News  Chris Linden on Facebook
VP - Human Resources
Chris Collins
  Chris Collins LinkedIn Profile  Chris Collins Twitter Account  Chris Collins News  Chris Collins on Facebook
VP - Marketing
Chip Moebus
  Chip Moebus LinkedIn Profile  Chip Moebus Twitter Account  Chip Moebus News  Chip Moebus on Facebook
VP - R & D
Bryan Cornwall
  Bryan Cornwall LinkedIn Profile  Bryan Cornwall Twitter Account  Bryan Cornwall News  Bryan Cornwall on Facebook
VP - Sales
Derek Matteo
  Derek Matteo LinkedIn Profile  Derek Matteo Twitter Account  Derek Matteo News  Derek Matteo on Facebook
VP - Sales
Corey Swift
  Corey Swift LinkedIn Profile  Corey Swift Twitter Account  Corey Swift News  Corey Swift on Facebook
VP - Sales
Elias Tu
  Elias Tu LinkedIn Profile  Elias Tu Twitter Account  Elias Tu News  Elias Tu on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/27/2024: Unseenlabs venture capital transaction
Next: 2/27/2024: Codified venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.